Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 3, 2019
UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIVPerrine Courlet, Dany Spaggiari, Vincent Desfontaine, et al.
Therapeutic Drug Monitoring|September 24, 2025
Therapeutic Drug Monitoring and Point-of-Care Technologies: Opportunities and Current ChallengesSandro Carrara, Nicolas Widmer, Francesca Rodino, et al.
The Journal of Antimicrobial Chemotherapy|November 4, 2021
Anticholinergic medication use in elderly people living with HIV and self-reported neurocognitive impairment: a prospective cohort studyBernadette Jakeman, Alexandra Scherrer, Manuel Battegay, et al.
JMIR Formative Research|August 17, 2022
Collaborative Challenges of Multi-Cohort Projects in Pharmacogenetics-Why Time Is Essential for Meaningful CollaborationsFilippo Franchini, Katharina Kusejko, Catia Marzolini, et al.
Global Cardiology Science & Practice|July 21, 2021
Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centreIoanna Istampoulouoglou, Barbara Zimmermanns, Tanja Grandinetti, et al.
AIDS (London, England)|September 7, 2019
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIVPerrine Courlet, Felix Stader, Monia Guidi, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 2011
Ageing with HIV: medication use and risk for potential drug-drug interactionsCatia Marzolini, David Back, Rainer Weber, et al.
Open Forum Infectious Diseases|January 8, 2020
Polypharmacy, Drug-Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIVPerrine Courlet, Françoise Livio, Monia Guidi, et al.
Pageof 14